4.
CRABPII和E-FABP在NSCLC原发癌中的差异性表达与各临床病理特征的关系
Relationship between difference expression of CRABPII and E-FABP and clinicopathological characteristics of NSCLC
| Characteristic | n | Difference expression between CRABPII and E-FABP | P | |
| E-FABP≥CRABPII | E-FABP < CRABPII | |||
| Gender | 0.118 | |||
| Male | 230 | 180 | 50 | |
| Female | 57 | 39 | 18 | |
| Age (year) | 0.332 | |||
| ≤61 | 154 | 121 | 33 | |
| > 61 | 133 | 98 | 35 | |
| Tumor size | 0.034 | |||
| Diameter ≤3 cm | 108 | 75 | 33 | |
| Diameter > 3 cm | 179 | 144 | 35 | |
| Histological type | 0.163 | |||
| Squamous cell carcinoma | 133 | 108 | 25 | |
| Adenocarcinoma | 126 | 92 | 34 | |
| Adenosquamous carcinoma | 28 | 19 | 9 | |
| Grading | 0.036 | |||
| Well | 13 | 7 | 6 | |
| Moderate | 144 | 118 | 26 | |
| Poor | 102 | 75 | 27 | |
| Metastasis | 0.029 | |||
| Yes | 143 | 117 | 26 | |
| No | 144 | 102 | 42 | |
| TNM staging | 0.018 | |||
| Ⅰ+Ⅱ | 154 | 109 | 45 | |
| Ⅲ+Ⅳ | 133 | 110 | 23 | |